Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5986 to 6000 of 7707 results

  1. Radioactive iodine: What is the clinical and cost effectiveness of RAI after total or completion thyroidectomy for people with T2 disease and no adverse pathological features?

    Recommendation ID NG230/05 Question Radioactive iodine: What is the clinical and cost effectiveness of RAI after total or completion thyroidectomy

    Research recommendation
    Published
    6 January 2023

  2. Stopping anticoagulation after ablation: What is the clinical and cost effectiveness of stopping anticoagulation in people whose atrial fibrillation has resolved after ablation?

    Recommendation ID NG196/3 Question Stopping anticoagulation after ablation: What is the clinical and cost effectiveness of stopping anticoagulation

    Research recommendation
    Published
    10 August 2021

  3. Stopping anticoagulation after resolution of postoperative atrial fibrillation: What is the clinical and cost effectiveness of stopping anticoagulation in people whose postoperative atrial fibrillation after cardiac surgery has resolved?

    Recommendation ID NG196/4 Question Stopping anticoagulation after resolution of postoperative atrial fibrillation: What is the clinical

    Research recommendation
    Published
    10 August 2021

  4. Subcutaneous methotrexate:- What is the clinical and cost effectiveness of subcutaneous methotrexate compared with oral methotrexate for adults with early onset RA starting a new DMARD?

    Recommendation ID NG100/6 Question Subcutaneous methotrexate:- What is the clinical and cost effectiveness of subcutaneous methotrexate

    Research recommendation
    Published
    11 December 2018

  5. Exercise: What is the clinical and cost effectiveness of supervised group and individual exercise compared with unsupervised exercise for people with osteoarthritis?

    Recommendation ID NG226/01 Question Exercise: What is the clinical and cost effectiveness of supervised group and individual exercise compared

    Research recommendation
    Published
    7 November 2022

  6. Alpha blockers and ureteroscopy- What is the clinical and cost effectiveness of tamsulosin as an adjunct to ureteroscopy?

    Recommendation ID NG118/2 Question Alpha blockers and ureteroscopy- What is the clinical and cost effectiveness of tamsulosin as an adjunct

    Research recommendation
    Published
    7 March 2019

  7. Monitoring antiseizure medications in women and girls: What is the clinical and cost effectiveness of therapeutic drug monitoring in girls, young women and women with epilepsy?

    Recommendation ID NG217/06 Question Monitoring antiseizure medications in women and girls: What is the clinical and cost effectiveness

    Research recommendation
    Published
    11 May 2022

  8. Topical and oral medicines:- What is the clinical and cost effectiveness of topical local anaesthetics for people with osteoarthritis? - What is the clinical and cost effectiveness of antiepileptics and antidepressants (other than duloxetine) for people with osteoarthritis? - What is the clinical and cost effectiveness of weak oral opioids for people with osteoarthritis?

    Recommendation ID NG226/10 Question Topical and oral medicines:- What is the clinical and cost effectiveness of topical local anaesthetics

    Research recommendation
    Published
    7 November 2022

  9. Topical medicines: What is the clinical and cost effectiveness of topical non-steroidal anti-inflammatory drugs and topical capsaicin for osteoarthritis-affected joints other than the knee?

    Recommendation ID NG226/03 Question Topical medicines: What is the clinical and cost effectiveness of topical non-steroidal anti-inflammatory

    Research recommendation
    Published
    7 November 2022

  10. Effectiveness of SGLT2 inhibitors for different ethnic groups: What is the clinical and cost effectiveness of SGLT2 inhibitors in adults with type 2 diabetes and chronic kidney disease, stratified across different ethnic groups?

    Recommendation ID NG28/05 Question Effectiveness of SGLT2 inhibitors for different ethnic groups: What is the clinical and cost effectiveness

    Research recommendation
    Published
    24 March 2022

  11. Post-discharge early follow-up clinics:- What is the clinical and cost effectiveness of post-discharge early follow-up clinics for people who have had a medical emergency and are at risk of unscheduled hospital readmission? [See the evidence review on post-discharge early follow-up clinics.]

    Recommendation ID NG94/16 Question Post-discharge early follow-up clinics:- What is the clinical and cost effectiveness of post-discharge

    Research recommendation
    Published
    15 November 2018

  12. Effectiveness of SGLT2 inhibitors for adults with a urine ACR below 3 mg/mmol: What is the clinical and cost effectiveness of SGLT2 inhibitors in adults with type 2 diabetes, chronic kidney disease and a urine ACR of less than 3 mg/mmol?

    Recommendation ID NG28/06 Question Effectiveness of SGLT2 inhibitors for adults with a urine ACR below 3 mg/mmol: What is the clinical

    Research recommendation
    Published
    24 March 2022

  13. Effectiveness of progestogens in women with recurrent miscarriage: What is the clinical and cost effectiveness of progesterone for improving outcomes in women with unexplained recurrent miscarriage?

    Recommendation ID NG126/03 Question Effectiveness of progestogens in women with recurrent miscarriage: What is the clinical and cost effectiveness

    Research recommendation
    Published
    17 December 2021

  14. Extended access to community nursing:- What is the clinical and cost effectiveness of providing extended access to community nursing, for example during evenings and weekends? [See the evidence review on community nursing.]

    Recommendation ID NG94/10 Question Extended access to community nursing:- What is the clinical and cost effectiveness of providing extended

    Research recommendation
    Published
    15 November 2018

  15. Short-term bridging treatment with glucocorticoids:- What is the clinical and cost effectiveness of short-term bridging treatment with glucocorticoids for adults with RA starting a new disease-modifying anti-rheumatic drug (DMARD), including the most effective dosing strategy and mode of administration?

    Recommendation ID NG100/2 Question Short-term bridging treatment with glucocorticoids:- What is the clinical and cost effectiveness of

    Research recommendation
    Published
    11 December 2018